Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.93
+0.62 (1.16%)
At close: Mar 17, 2026, 4:00 PM EDT
54.18
+0.25 (0.46%)
After-hours: Mar 17, 2026, 7:18 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $21.3 billion as of March 17, 2026. Its market cap has increased by 78.31% in one year.
Market Cap
21.30B
Enterprise Value
14.47B
1-Year Change
78.31%
Ranking
Category
Stock Price
$53.93
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $21.30B, an increase of 248.11%. That is a compound annual growth rate of 18.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 21.05B | 82.72% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 31.49B |
| Insmed | 30.07B |
| BioNTech SE | 22.92B |
| Roivant Sciences | 20.08B |
| Royalty Pharma | 19.56B |
| Revolution Medicines | 18.80B |
| Incyte | 18.42B |
| Genmab | 16.79B |